Proapoptotic compound ARC targets Akt and N-myc in neuroblastoma cells. (Q40088634)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17724478%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

Proapoptotic compound ARC targets Akt and N-myc in neuroblastoma cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17724478%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

Senthil K Radhakrishnan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17724478%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

Halasi M

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17724478%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Bhat UG

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17724478%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Kurmasheva RT

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17724478%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Houghton PJ

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17724478%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Gartel AL

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17724478%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

language of work or name

English

0 references

publication date

3 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17724478%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17724478%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17724478%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17724478%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

694-699

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17724478%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210692

4 January 2020

exact match

0 references

cites work

Neuroblastoma: biological insights into a clinical enigma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210692

A comparison of current neuroblastoma chemotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210692

Outcome of high-risk neuroblastoma using a dose intensity approach: improvement in initial but not in long-term results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210692

Inhibition of phosphatidylinositol 3-kinase destabilizes Mycn protein and blocks malignant progression in neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210692

Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210692

Neuroblastoma: evolving therapies for a disease with many faces

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210692

Clinical trials using irinotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210692

Improved survival of children with advanced neuroblastoma treated by intensified therapy including myeloablative chemotherapy with stem cell transplantation: a retrospective analysis from the Tohoku Neuroblastoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210692

Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210692

Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210692

Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210692

Control of formation of two distinct classes of RNA polymerase II elongation complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210692

Breaking the mitochondrial barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210692

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210692

Identification of a chemical inhibitor of the oncogenic transcription factor forkhead box M1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210692

Constitutive expression of E2F-1 leads to p21-dependent cell cycle arrest in S phase of the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210692

A novel transcriptional inhibitor induces apoptosis in tumor cells and exhibits antiangiogenic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210692

Development, characterization and therapy of a disseminated model of childhood neuroblastoma in SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210692

Pediatric neuroblastomas: genetic and epigenetic 'danse macabre'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210692

Expression of the Gene for Multidrug-Resistance–Associated Protein and Outcome in Patients with Neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210692

Results of the cooperative protocol (N-III-95) for metastatic relapses and refractory neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210692

7 January 2021

Direct translation of a protracted irinotecan schedule from a xenograft model to a phase I trial in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210692

7 January 2021

RNA polymerase II elongation control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210692

7 January 2021

CDK9 phosphorylates p53 on serine residues 33, 315 and 392

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210692

7 January 2021

Consolidation with a busulfan-containing regimen followed by stem cell transplantation in infants with poor prognosis stage 4 neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210692

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1210692

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17724478%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

4 January 2020

0 references

1 reference